Joint Venture formed by Bio-Techne, Fresenius Kabi, and Wilson Wolf

The joint venture focuses on providing scalable manufacturing technologies needed to develop and commercialize new cell and gene therapies. Each partner contributes industry-leading products and unique expertise to the new venture.